Vimarsana
Biggest News Aggregation in the World

Page 3 - Long Term Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Long Term Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Long Term Study Today - Breaking & Trending Today

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years - Vimarsana News

Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years

/PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™...

Larner College of Medicine seeking millennials for long-term Lung Health Cohort Study - Vimarsana News

Larner College of Medicine seeking millennials for long-term Lung Health Cohort Study

"There are a lot of new elements to factors that can really impact our lung health."

Source: mynbc5.com
Vitamin-Cocktail gegen Demenz? - Vimarsana News

Vitamin-Cocktail gegen Demenz?

Gegen den Abbau: Eine Langzeitstudie liefert Hinweise darauf, dass Vitamine und Spurenelemente den geistigen Abbau im Alter zumindest verzögern können.

Source: scinexx.de
Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting - Vimarsana News

Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its movement disorder treatments for...

Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting - Vimarsana News

Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its movement disorder treatments for...